nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—Mitiglinide—Nateglinide—type 2 diabetes mellitus	0.183	0.622	CrCrCtD
Nelfinavir—Mitiglinide—Ramipril—type 2 diabetes mellitus	0.111	0.378	CrCrCtD
Nelfinavir—CYP1A2—type 2 diabetes mellitus	0.103	0.602	CbGaD
Nelfinavir—CYP3A4—type 2 diabetes mellitus	0.0684	0.398	CbGaD
Nelfinavir—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0227	0.0599	CbGbCtD
Nelfinavir—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0206	0.0542	CbGbCtD
Nelfinavir—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0194	0.0512	CbGbCtD
Nelfinavir—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.019	0.05	CbGbCtD
Nelfinavir—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0168	0.0442	CbGbCtD
Nelfinavir—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0112	0.0294	CbGbCtD
Nelfinavir—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00963	0.0254	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00914	0.0241	CbGbCtD
Nelfinavir—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00914	0.0241	CbGbCtD
Nelfinavir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00914	0.0241	CbGbCtD
Nelfinavir—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00859	0.0226	CbGbCtD
Nelfinavir—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0084	0.0221	CbGbCtD
Nelfinavir—ABCG2—Glyburide—type 2 diabetes mellitus	0.00836	0.022	CbGbCtD
Nelfinavir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00815	0.0215	CbGbCtD
Nelfinavir—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00768	0.0202	CbGbCtD
Nelfinavir—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0073	0.0192	CbGbCtD
Nelfinavir—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0073	0.0192	CbGbCtD
Nelfinavir—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00714	0.0188	CbGbCtD
Nelfinavir—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00686	0.0181	CbGbCtD
Nelfinavir—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00674	0.0177	CbGbCtD
Nelfinavir—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00651	0.0171	CbGbCtD
Nelfinavir—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00622	0.0164	CbGbCtD
Nelfinavir—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00607	0.016	CbGbCtD
Nelfinavir—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00607	0.016	CbGbCtD
Nelfinavir—SLC22A1—Metformin—type 2 diabetes mellitus	0.00596	0.0157	CbGbCtD
Nelfinavir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00589	0.0155	CbGbCtD
Nelfinavir—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0056	0.0148	CbGbCtD
Nelfinavir—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00555	0.0146	CbGbCtD
Nelfinavir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00548	0.0144	CbGbCtD
Nelfinavir—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00541	0.0143	CbGbCtD
Nelfinavir—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00512	0.0135	CbGbCtD
Nelfinavir—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00495	0.013	CbGbCtD
Nelfinavir—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00489	0.0129	CbGbCtD
Nelfinavir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00488	0.0129	CbGbCtD
Nelfinavir—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00463	0.0122	CbGbCtD
Nelfinavir—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0046	0.0121	CbGbCtD
Nelfinavir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00446	0.0118	CbGbCtD
Nelfinavir—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00441	0.0116	CbGbCtD
Nelfinavir—CYP3A5—Losartan—type 2 diabetes mellitus	0.00424	0.0112	CbGbCtD
Nelfinavir—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00421	0.0111	CbGbCtD
Nelfinavir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00405	0.0107	CbGbCtD
Nelfinavir—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00403	0.0106	CbGbCtD
Nelfinavir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0039	0.0103	CbGbCtD
Nelfinavir—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00374	0.00984	CbGbCtD
Nelfinavir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00353	0.0093	CbGbCtD
Nelfinavir—CYP2C19—Losartan—type 2 diabetes mellitus	0.00342	0.009	CbGbCtD
Nelfinavir—CYP1A2—Losartan—type 2 diabetes mellitus	0.00315	0.00831	CbGbCtD
Nelfinavir—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00311	0.00818	CbGbCtD
Nelfinavir—ABCB1—Glyburide—type 2 diabetes mellitus	0.00302	0.00794	CbGbCtD
Nelfinavir—CYP2C9—Losartan—type 2 diabetes mellitus	0.00284	0.00749	CbGbCtD
Nelfinavir—ABCB1—Losartan—type 2 diabetes mellitus	0.00276	0.00726	CbGbCtD
Nelfinavir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00267	0.00705	CbGbCtD
Nelfinavir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00256	0.00675	CbGbCtD
Nelfinavir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00256	0.00675	CbGbCtD
Nelfinavir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00242	0.00639	CbGbCtD
Nelfinavir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00181	0.00476	CbGbCtD
Nelfinavir—CYP3A4—Losartan—type 2 diabetes mellitus	0.00165	0.00435	CbGbCtD
Nelfinavir—Mitiglinide—ABCC8—type 2 diabetes mellitus	0.000784	0.273	CrCbGaD
Nelfinavir—Mitiglinide—KCNJ11—type 2 diabetes mellitus	0.000552	0.193	CrCbGaD
Nelfinavir—Saquinavir—CYP11A1—type 2 diabetes mellitus	0.000399	0.139	CrCbGaD
Nelfinavir—Mitiglinide—PPARG—type 2 diabetes mellitus	0.000306	0.107	CrCbGaD
Nelfinavir—Indinavir—ABCC2—type 2 diabetes mellitus	0.000294	0.103	CrCbGaD
Nelfinavir—Saquinavir—ABCC2—type 2 diabetes mellitus	0.000219	0.0765	CrCbGaD
Nelfinavir—Indinavir—CYP3A4—type 2 diabetes mellitus	0.00013	0.0453	CrCbGaD
Nelfinavir—Saquinavir—CYP3A4—type 2 diabetes mellitus	9.7e-05	0.0338	CrCbGaD
Nelfinavir—Saquinavir—ALB—type 2 diabetes mellitus	8.46e-05	0.0295	CrCbGaD
Nelfinavir—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000673	CcSEcCtD
Nelfinavir—Flatulence—Losartan—type 2 diabetes mellitus	7.14e-05	0.000672	CcSEcCtD
Nelfinavir—Hepatitis—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000672	CcSEcCtD
Nelfinavir—Anaemia—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.00067	CcSEcCtD
Nelfinavir—Dizziness—Glimepiride—type 2 diabetes mellitus	7.11e-05	0.000669	CcSEcCtD
Nelfinavir—Skin disorder—Valsartan—type 2 diabetes mellitus	7.1e-05	0.000669	CcSEcCtD
Nelfinavir—Dyspnoea—Gliclazide—type 2 diabetes mellitus	7.09e-05	0.000668	CcSEcCtD
Nelfinavir—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.08e-05	0.000667	CcSEcCtD
Nelfinavir—Agitation—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000666	CcSEcCtD
Nelfinavir—Somnolence—Gliclazide—type 2 diabetes mellitus	7.07e-05	0.000666	CcSEcCtD
Nelfinavir—Urticaria—Glyburide—type 2 diabetes mellitus	7.04e-05	0.000663	CcSEcCtD
Nelfinavir—Skin disorder—Orlistat—type 2 diabetes mellitus	7.02e-05	0.000661	CcSEcCtD
Nelfinavir—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	7.01e-05	0.00066	CcSEcCtD
Nelfinavir—Back pain—Losartan—type 2 diabetes mellitus	7.01e-05	0.00066	CcSEcCtD
Nelfinavir—Abdominal pain—Glyburide—type 2 diabetes mellitus	7.01e-05	0.00066	CcSEcCtD
Nelfinavir—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7e-05	0.00066	CcSEcCtD
Nelfinavir—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	6.98e-05	0.000658	CcSEcCtD
Nelfinavir—Anorexia—Valsartan—type 2 diabetes mellitus	6.97e-05	0.000656	CcSEcCtD
Nelfinavir—Muscle spasms—Losartan—type 2 diabetes mellitus	6.97e-05	0.000656	CcSEcCtD
Nelfinavir—Asthenia—Bromocriptine—type 2 diabetes mellitus	6.96e-05	0.000655	CcSEcCtD
Nelfinavir—Myalgia—Metformin—type 2 diabetes mellitus	6.95e-05	0.000654	CcSEcCtD
Nelfinavir—Malaise—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000654	CcSEcCtD
Nelfinavir—Headache—Pioglitazone—type 2 diabetes mellitus	6.91e-05	0.000651	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	6.9e-05	0.00065	CcSEcCtD
Nelfinavir—Leukopenia—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000649	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.000647	CcSEcCtD
Nelfinavir—Discomfort—Metformin—type 2 diabetes mellitus	6.86e-05	0.000646	CcSEcCtD
Nelfinavir—Nausea—Glipizide—type 2 diabetes mellitus	6.84e-05	0.000644	CcSEcCtD
Nelfinavir—Vomiting—Glimepiride—type 2 diabetes mellitus	6.83e-05	0.000643	CcSEcCtD
Nelfinavir—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.81e-05	0.000641	CcSEcCtD
Nelfinavir—Pain—Gliclazide—type 2 diabetes mellitus	6.81e-05	0.000641	CcSEcCtD
Nelfinavir—Rash—Glimepiride—type 2 diabetes mellitus	6.78e-05	0.000638	CcSEcCtD
Nelfinavir—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.77e-05	0.000637	CcSEcCtD
Nelfinavir—Rash—Sitagliptin—type 2 diabetes mellitus	6.75e-05	0.000636	CcSEcCtD
Nelfinavir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.75e-05	0.000635	CcSEcCtD
Nelfinavir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000635	CcSEcCtD
Nelfinavir—Headache—Glimepiride—type 2 diabetes mellitus	6.73e-05	0.000634	CcSEcCtD
Nelfinavir—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.72e-05	0.000633	CcSEcCtD
Nelfinavir—Headache—Sitagliptin—type 2 diabetes mellitus	6.71e-05	0.000632	CcSEcCtD
Nelfinavir—Anaemia—Losartan—type 2 diabetes mellitus	6.7e-05	0.000631	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000627	CcSEcCtD
Nelfinavir—Agitation—Losartan—type 2 diabetes mellitus	6.66e-05	0.000627	CcSEcCtD
Nelfinavir—Oedema—Metformin—type 2 diabetes mellitus	6.66e-05	0.000627	CcSEcCtD
Nelfinavir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.63e-05	0.000625	CcSEcCtD
Nelfinavir—Insomnia—Valsartan—type 2 diabetes mellitus	6.61e-05	0.000623	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.58e-05	0.00062	CcSEcCtD
Nelfinavir—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.57e-05	0.000618	CcSEcCtD
Nelfinavir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000618	CcSEcCtD
Nelfinavir—Myalgia—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000617	CcSEcCtD
Nelfinavir—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000617	CcSEcCtD
Nelfinavir—Insomnia—Orlistat—type 2 diabetes mellitus	6.53e-05	0.000615	CcSEcCtD
Nelfinavir—Malaise—Losartan—type 2 diabetes mellitus	6.53e-05	0.000615	CcSEcCtD
Nelfinavir—Anxiety—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000615	CcSEcCtD
Nelfinavir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.53e-05	0.000615	CcSEcCtD
Nelfinavir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.52e-05	0.000614	CcSEcCtD
Nelfinavir—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000614	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.51e-05	0.000613	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.51e-05	0.000613	CcSEcCtD
Nelfinavir—Somnolence—Valsartan—type 2 diabetes mellitus	6.5e-05	0.000612	CcSEcCtD
Nelfinavir—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.49e-05	0.000611	CcSEcCtD
Nelfinavir—Leukopenia—Losartan—type 2 diabetes mellitus	6.49e-05	0.000611	CcSEcCtD
Nelfinavir—Discomfort—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.00061	CcSEcCtD
Nelfinavir—Skin disorder—Metformin—type 2 diabetes mellitus	6.47e-05	0.000609	CcSEcCtD
Nelfinavir—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000607	CcSEcCtD
Nelfinavir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.44e-05	0.000606	CcSEcCtD
Nelfinavir—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.44e-05	0.000606	CcSEcCtD
Nelfinavir—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.41e-05	0.000604	CcSEcCtD
Nelfinavir—Nausea—Glimepiride—type 2 diabetes mellitus	6.38e-05	0.000601	CcSEcCtD
Nelfinavir—Nausea—Sitagliptin—type 2 diabetes mellitus	6.36e-05	0.000599	CcSEcCtD
Nelfinavir—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.36e-05	0.000599	CcSEcCtD
Nelfinavir—Asthenia—Glyburide—type 2 diabetes mellitus	6.36e-05	0.000599	CcSEcCtD
Nelfinavir—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.36e-05	0.000599	CcSEcCtD
Nelfinavir—Anorexia—Metformin—type 2 diabetes mellitus	6.35e-05	0.000598	CcSEcCtD
Nelfinavir—Urticaria—Gliclazide—type 2 diabetes mellitus	6.32e-05	0.000595	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.31e-05	0.000594	CcSEcCtD
Nelfinavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.29e-05	0.000592	CcSEcCtD
Nelfinavir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.29e-05	0.000592	CcSEcCtD
Nelfinavir—Oedema—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000592	CcSEcCtD
Nelfinavir—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.28e-05	0.000591	CcSEcCtD
Nelfinavir—Pruritus—Glyburide—type 2 diabetes mellitus	6.27e-05	0.00059	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000587	CcSEcCtD
Nelfinavir—Malnutrition—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000585	CcSEcCtD
Nelfinavir—Erythema—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000585	CcSEcCtD
Nelfinavir—Pain—Orlistat—type 2 diabetes mellitus	6.18e-05	0.000582	CcSEcCtD
Nelfinavir—Arthralgia—Losartan—type 2 diabetes mellitus	6.17e-05	0.000581	CcSEcCtD
Nelfinavir—Myalgia—Losartan—type 2 diabetes mellitus	6.17e-05	0.000581	CcSEcCtD
Nelfinavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.16e-05	0.00058	CcSEcCtD
Nelfinavir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000579	CcSEcCtD
Nelfinavir—Anxiety—Losartan—type 2 diabetes mellitus	6.15e-05	0.000579	CcSEcCtD
Nelfinavir—Rash—Bromocriptine—type 2 diabetes mellitus	6.11e-05	0.000576	CcSEcCtD
Nelfinavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.11e-05	0.000575	CcSEcCtD
Nelfinavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.000575	CcSEcCtD
Nelfinavir—Discomfort—Losartan—type 2 diabetes mellitus	6.09e-05	0.000574	CcSEcCtD
Nelfinavir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.000572	CcSEcCtD
Nelfinavir—Headache—Bromocriptine—type 2 diabetes mellitus	6.07e-05	0.000572	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.07e-05	0.000571	CcSEcCtD
Nelfinavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.06e-05	0.000571	CcSEcCtD
Nelfinavir—Anorexia—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000564	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.98e-05	0.000563	CcSEcCtD
Nelfinavir—Paraesthesia—Metformin—type 2 diabetes mellitus	5.98e-05	0.000563	CcSEcCtD
Nelfinavir—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000562	CcSEcCtD
Nelfinavir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000561	CcSEcCtD
Nelfinavir—Dyspnoea—Metformin—type 2 diabetes mellitus	5.94e-05	0.000559	CcSEcCtD
Nelfinavir—Somnolence—Metformin—type 2 diabetes mellitus	5.92e-05	0.000557	CcSEcCtD
Nelfinavir—Oedema—Losartan—type 2 diabetes mellitus	5.91e-05	0.000557	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.91e-05	0.000556	CcSEcCtD
Nelfinavir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.86e-05	0.000552	CcSEcCtD
Nelfinavir—Dyspepsia—Metformin—type 2 diabetes mellitus	5.86e-05	0.000552	CcSEcCtD
Nelfinavir—Urticaria—Valsartan—type 2 diabetes mellitus	5.81e-05	0.000547	CcSEcCtD
Nelfinavir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.79e-05	0.000545	CcSEcCtD
Nelfinavir—Decreased appetite—Metformin—type 2 diabetes mellitus	5.79e-05	0.000545	CcSEcCtD
Nelfinavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.78e-05	0.000544	CcSEcCtD
Nelfinavir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000543	CcSEcCtD
Nelfinavir—Nausea—Bromocriptine—type 2 diabetes mellitus	5.76e-05	0.000542	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.75e-05	0.000541	CcSEcCtD
Nelfinavir—Urticaria—Orlistat—type 2 diabetes mellitus	5.74e-05	0.00054	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000539	CcSEcCtD
Nelfinavir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.72e-05	0.000538	CcSEcCtD
Nelfinavir—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.71e-05	0.000538	CcSEcCtD
Nelfinavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.71e-05	0.000538	CcSEcCtD
Nelfinavir—Asthenia—Gliclazide—type 2 diabetes mellitus	5.71e-05	0.000538	CcSEcCtD
Nelfinavir—Agitation—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000538	CcSEcCtD
Nelfinavir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000531	CcSEcCtD
Nelfinavir—Anorexia—Losartan—type 2 diabetes mellitus	5.64e-05	0.000531	CcSEcCtD
Nelfinavir—Vomiting—Glyburide—type 2 diabetes mellitus	5.63e-05	0.000531	CcSEcCtD
Nelfinavir—Pruritus—Gliclazide—type 2 diabetes mellitus	5.63e-05	0.00053	CcSEcCtD
Nelfinavir—Malaise—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000528	CcSEcCtD
Nelfinavir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000528	CcSEcCtD
Nelfinavir—Rash—Glyburide—type 2 diabetes mellitus	5.59e-05	0.000526	CcSEcCtD
Nelfinavir—Somnolence—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000526	CcSEcCtD
Nelfinavir—Dermatitis—Glyburide—type 2 diabetes mellitus	5.58e-05	0.000526	CcSEcCtD
Nelfinavir—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	5.58e-05	0.0647	CbGeAlD
Nelfinavir—Leukopenia—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000524	CcSEcCtD
Nelfinavir—Headache—Glyburide—type 2 diabetes mellitus	5.55e-05	0.000523	CcSEcCtD
Nelfinavir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000521	CcSEcCtD
Nelfinavir—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.49e-05	0.000517	CcSEcCtD
Nelfinavir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.46e-05	0.000514	CcSEcCtD
Nelfinavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.44e-05	0.000513	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.44e-05	0.000513	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.42e-05	0.000511	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.39e-05	0.000507	CcSEcCtD
Nelfinavir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.39e-05	0.000507	CcSEcCtD
Nelfinavir—Convulsion—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000507	CcSEcCtD
Nelfinavir—Pain—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.000506	CcSEcCtD
Nelfinavir—Insomnia—Losartan—type 2 diabetes mellitus	5.35e-05	0.000504	CcSEcCtD
Nelfinavir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.32e-05	0.000501	CcSEcCtD
Nelfinavir—Paraesthesia—Losartan—type 2 diabetes mellitus	5.31e-05	0.0005	CcSEcCtD
Nelfinavir—Urticaria—Metformin—type 2 diabetes mellitus	5.29e-05	0.000498	CcSEcCtD
Nelfinavir—Myalgia—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000498	CcSEcCtD
Nelfinavir—Arthralgia—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000498	CcSEcCtD
Nelfinavir—Dyspnoea—Losartan—type 2 diabetes mellitus	5.27e-05	0.000496	CcSEcCtD
Nelfinavir—Anxiety—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000496	CcSEcCtD
Nelfinavir—Nausea—Glyburide—type 2 diabetes mellitus	5.26e-05	0.000496	CcSEcCtD
Nelfinavir—Abdominal pain—Metformin—type 2 diabetes mellitus	5.26e-05	0.000496	CcSEcCtD
Nelfinavir—Dizziness—Gliclazide—type 2 diabetes mellitus	5.26e-05	0.000496	CcSEcCtD
Nelfinavir—Somnolence—Losartan—type 2 diabetes mellitus	5.26e-05	0.000495	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000495	CcSEcCtD
Nelfinavir—Asthenia—Valsartan—type 2 diabetes mellitus	5.25e-05	0.000494	CcSEcCtD
Nelfinavir—Discomfort—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000492	CcSEcCtD
Nelfinavir—Dyspepsia—Losartan—type 2 diabetes mellitus	5.21e-05	0.00049	CcSEcCtD
Nelfinavir—Asthenia—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000488	CcSEcCtD
Nelfinavir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000488	CcSEcCtD
Nelfinavir—Pruritus—Valsartan—type 2 diabetes mellitus	5.17e-05	0.000487	CcSEcCtD
Nelfinavir—Decreased appetite—Losartan—type 2 diabetes mellitus	5.14e-05	0.000484	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000484	CcSEcCtD
Nelfinavir—Pruritus—Orlistat—type 2 diabetes mellitus	5.11e-05	0.000481	CcSEcCtD
Nelfinavir—Oedema—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000477	CcSEcCtD
Nelfinavir—Vomiting—Gliclazide—type 2 diabetes mellitus	5.06e-05	0.000476	CcSEcCtD
Nelfinavir—Pain—Losartan—type 2 diabetes mellitus	5.06e-05	0.000476	CcSEcCtD
Nelfinavir—Rash—Gliclazide—type 2 diabetes mellitus	5.02e-05	0.000472	CcSEcCtD
Nelfinavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000472	CcSEcCtD
Nelfinavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	5e-05	0.000471	CcSEcCtD
Nelfinavir—Urticaria—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.00047	CcSEcCtD
Nelfinavir—Headache—Gliclazide—type 2 diabetes mellitus	4.99e-05	0.000469	CcSEcCtD
Nelfinavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000468	CcSEcCtD
Nelfinavir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000468	CcSEcCtD
Nelfinavir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000467	CcSEcCtD
Nelfinavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.94e-05	0.000465	CcSEcCtD
Nelfinavir—Skin disorder—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000464	CcSEcCtD
Nelfinavir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000462	CcSEcCtD
Nelfinavir—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.87e-05	0.000459	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.84e-05	0.000455	CcSEcCtD
Nelfinavir—Dizziness—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000455	CcSEcCtD
Nelfinavir—Anorexia—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000455	CcSEcCtD
Nelfinavir—Dizziness—Orlistat—type 2 diabetes mellitus	4.78e-05	0.00045	CcSEcCtD
Nelfinavir—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	4.78e-05	0.0554	CbGeAlD
Nelfinavir—Asthenia—Metformin—type 2 diabetes mellitus	4.78e-05	0.00045	CcSEcCtD
Nelfinavir—Nausea—Gliclazide—type 2 diabetes mellitus	4.73e-05	0.000445	CcSEcCtD
Nelfinavir—Pruritus—Metformin—type 2 diabetes mellitus	4.71e-05	0.000444	CcSEcCtD
Nelfinavir—Urticaria—Losartan—type 2 diabetes mellitus	4.7e-05	0.000442	CcSEcCtD
Nelfinavir—Body temperature increased—Losartan—type 2 diabetes mellitus	4.67e-05	0.00044	CcSEcCtD
Nelfinavir—Abdominal pain—Losartan—type 2 diabetes mellitus	4.67e-05	0.00044	CcSEcCtD
Nelfinavir—Vomiting—Valsartan—type 2 diabetes mellitus	4.65e-05	0.000438	CcSEcCtD
Nelfinavir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000436	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000435	CcSEcCtD
Nelfinavir—Rash—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000434	CcSEcCtD
Nelfinavir—Dermatitis—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000434	CcSEcCtD
Nelfinavir—Vomiting—Orlistat—type 2 diabetes mellitus	4.59e-05	0.000433	CcSEcCtD
Nelfinavir—Insomnia—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000432	CcSEcCtD
Nelfinavir—Headache—Valsartan—type 2 diabetes mellitus	4.58e-05	0.000431	CcSEcCtD
Nelfinavir—Diarrhoea—Metformin—type 2 diabetes mellitus	4.56e-05	0.000429	CcSEcCtD
Nelfinavir—Rash—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000429	CcSEcCtD
Nelfinavir—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000429	CcSEcCtD
Nelfinavir—Dermatitis—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000429	CcSEcCtD
Nelfinavir—Headache—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000426	CcSEcCtD
Nelfinavir—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000426	CcSEcCtD
Nelfinavir—Asthenia—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000425	CcSEcCtD
Nelfinavir—Somnolence—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000424	CcSEcCtD
Nelfinavir—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.00042	CcSEcCtD
Nelfinavir—Pruritus—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000419	CcSEcCtD
Nelfinavir—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000415	CcSEcCtD
Nelfinavir—Dizziness—Metformin—type 2 diabetes mellitus	4.4e-05	0.000415	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000412	CcSEcCtD
Nelfinavir—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.36e-05	0.00041	CcSEcCtD
Nelfinavir—Nausea—Valsartan—type 2 diabetes mellitus	4.34e-05	0.000409	CcSEcCtD
Nelfinavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000405	CcSEcCtD
Nelfinavir—Nausea—Orlistat—type 2 diabetes mellitus	4.29e-05	0.000404	CcSEcCtD
Nelfinavir—Asthenia—Losartan—type 2 diabetes mellitus	4.24e-05	0.0004	CcSEcCtD
Nelfinavir—Vomiting—Metformin—type 2 diabetes mellitus	4.23e-05	0.000399	CcSEcCtD
Nelfinavir—Rash—Metformin—type 2 diabetes mellitus	4.2e-05	0.000395	CcSEcCtD
Nelfinavir—Dermatitis—Metformin—type 2 diabetes mellitus	4.19e-05	0.000395	CcSEcCtD
Nelfinavir—Pruritus—Losartan—type 2 diabetes mellitus	4.18e-05	0.000394	CcSEcCtD
Nelfinavir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000393	CcSEcCtD
Nelfinavir—Headache—Metformin—type 2 diabetes mellitus	4.17e-05	0.000393	CcSEcCtD
Nelfinavir—Dizziness—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000391	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.15e-05	0.00039	CcSEcCtD
Nelfinavir—Diarrhoea—Losartan—type 2 diabetes mellitus	4.05e-05	0.000381	CcSEcCtD
Nelfinavir—Urticaria—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000379	CcSEcCtD
Nelfinavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000377	CcSEcCtD
Nelfinavir—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000377	CcSEcCtD
Nelfinavir—Vomiting—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000376	CcSEcCtD
Nelfinavir—Rash—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000373	CcSEcCtD
Nelfinavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000373	CcSEcCtD
Nelfinavir—SLCO1B1—kidney—type 2 diabetes mellitus	3.96e-05	0.0458	CbGeAlD
Nelfinavir—Nausea—Metformin—type 2 diabetes mellitus	3.95e-05	0.000372	CcSEcCtD
Nelfinavir—Headache—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000371	CcSEcCtD
Nelfinavir—Dizziness—Losartan—type 2 diabetes mellitus	3.91e-05	0.000368	CcSEcCtD
Nelfinavir—Vomiting—Losartan—type 2 diabetes mellitus	3.76e-05	0.000354	CcSEcCtD
Nelfinavir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000352	CcSEcCtD
Nelfinavir—Nausea—Irbesartan—type 2 diabetes mellitus	3.73e-05	0.000351	CcSEcCtD
Nelfinavir—Rash—Losartan—type 2 diabetes mellitus	3.73e-05	0.000351	CcSEcCtD
Nelfinavir—Dermatitis—Losartan—type 2 diabetes mellitus	3.72e-05	0.000351	CcSEcCtD
Nelfinavir—Headache—Losartan—type 2 diabetes mellitus	3.7e-05	0.000349	CcSEcCtD
Nelfinavir—CYP3A7—liver—type 2 diabetes mellitus	3.65e-05	0.0423	CbGeAlD
Nelfinavir—Asthenia—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000343	CcSEcCtD
Nelfinavir—Pruritus—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000338	CcSEcCtD
Nelfinavir—Nausea—Losartan—type 2 diabetes mellitus	3.51e-05	0.000331	CcSEcCtD
Nelfinavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000327	CcSEcCtD
Nelfinavir—Dizziness—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000316	CcSEcCtD
Nelfinavir—SLC22A1—kidney—type 2 diabetes mellitus	3.34e-05	0.0387	CbGeAlD
Nelfinavir—Vomiting—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000304	CcSEcCtD
Nelfinavir—SLCO1A2—kidney—type 2 diabetes mellitus	3.22e-05	0.0373	CbGeAlD
Nelfinavir—Rash—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000301	CcSEcCtD
Nelfinavir—Dermatitis—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000301	CcSEcCtD
Nelfinavir—Headache—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000299	CcSEcCtD
Nelfinavir—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	3.1e-05	0.0359	CbGeAlD
Nelfinavir—SLC22A1—adipose tissue—type 2 diabetes mellitus	3.01e-05	0.0349	CbGeAlD
Nelfinavir—Nausea—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000284	CcSEcCtD
Nelfinavir—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	2.87e-05	0.0333	CbGeAlD
Nelfinavir—SLCO1B1—liver—type 2 diabetes mellitus	2.5e-05	0.029	CbGeAlD
Nelfinavir—ABCG2—nephron tubule—type 2 diabetes mellitus	2.49e-05	0.0288	CbGeAlD
Nelfinavir—CYP3A5—nephron tubule—type 2 diabetes mellitus	2.31e-05	0.0268	CbGeAlD
Nelfinavir—CYP2B6—nephron tubule—type 2 diabetes mellitus	2.3e-05	0.0266	CbGeAlD
Nelfinavir—SLC22A1—liver—type 2 diabetes mellitus	2.11e-05	0.0245	CbGeAlD
Nelfinavir—CYP2B6—cardiovascular system—type 2 diabetes mellitus	2.06e-05	0.0239	CbGeAlD
Nelfinavir—CYP2C9—cardiovascular system—type 2 diabetes mellitus	2.04e-05	0.0237	CbGeAlD
Nelfinavir—SLCO1A2—liver—type 2 diabetes mellitus	2.03e-05	0.0236	CbGeAlD
Nelfinavir—CYP3A5—kidney—type 2 diabetes mellitus	2.03e-05	0.0235	CbGeAlD
Nelfinavir—CYP2B6—kidney—type 2 diabetes mellitus	2.02e-05	0.0234	CbGeAlD
Nelfinavir—CYP3A5—pancreas—type 2 diabetes mellitus	2.02e-05	0.0234	CbGeAlD
Nelfinavir—CYP3A5—cortex of kidney—type 2 diabetes mellitus	1.98e-05	0.0229	CbGeAlD
Nelfinavir—ABCG2—adipose tissue—type 2 diabetes mellitus	1.97e-05	0.0228	CbGeAlD
Nelfinavir—CYP3A5—adipose tissue—type 2 diabetes mellitus	1.83e-05	0.0212	CbGeAlD
Nelfinavir—CYP2C19—liver—type 2 diabetes mellitus	1.63e-05	0.0189	CbGeAlD
Nelfinavir—ABCB1—islet of Langerhans—type 2 diabetes mellitus	1.52e-05	0.0177	CbGeAlD
Nelfinavir—CYP3A4—kidney—type 2 diabetes mellitus	1.52e-05	0.0177	CbGeAlD
Nelfinavir—CYP2D6—kidney—type 2 diabetes mellitus	1.5e-05	0.0174	CbGeAlD
Nelfinavir—ABCG2—liver—type 2 diabetes mellitus	1.38e-05	0.016	CbGeAlD
Nelfinavir—CYP1A2—liver—type 2 diabetes mellitus	1.33e-05	0.0154	CbGeAlD
Nelfinavir—ABCB1—retina—type 2 diabetes mellitus	1.3e-05	0.0151	CbGeAlD
Nelfinavir—CYP3A5—liver—type 2 diabetes mellitus	1.28e-05	0.0149	CbGeAlD
Nelfinavir—CYP2B6—liver—type 2 diabetes mellitus	1.28e-05	0.0148	CbGeAlD
Nelfinavir—CYP2C9—liver—type 2 diabetes mellitus	1.26e-05	0.0146	CbGeAlD
Nelfinavir—ABCB1—nephron tubule—type 2 diabetes mellitus	1.23e-05	0.0142	CbGeAlD
Nelfinavir—ABCB1—cardiovascular system—type 2 diabetes mellitus	1.1e-05	0.0128	CbGeAlD
Nelfinavir—ABCB1—kidney—type 2 diabetes mellitus	1.08e-05	0.0125	CbGeAlD
Nelfinavir—ABCB1—pancreas—type 2 diabetes mellitus	1.07e-05	0.0124	CbGeAlD
Nelfinavir—ABCB1—cortex of kidney—type 2 diabetes mellitus	1.05e-05	0.0122	CbGeAlD
Nelfinavir—ABCB1—adipose tissue—type 2 diabetes mellitus	9.72e-06	0.0113	CbGeAlD
Nelfinavir—CYP3A4—liver—type 2 diabetes mellitus	9.63e-06	0.0112	CbGeAlD
Nelfinavir—CYP2D6—liver—type 2 diabetes mellitus	9.48e-06	0.011	CbGeAlD
Nelfinavir—ABCB1—liver—type 2 diabetes mellitus	6.82e-06	0.0079	CbGeAlD
Nelfinavir—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.62e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.62e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.62e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.62e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.62e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.61e-06	5.95e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	2.6e-06	5.93e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	2.6e-06	5.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.59e-06	5.9e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.59e-06	5.89e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	2.59e-06	5.89e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.58e-06	5.88e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.58e-06	5.88e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	2.57e-06	5.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.56e-06	5.84e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.56e-06	5.83e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.56e-06	5.83e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	2.52e-06	5.74e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.52e-06	5.74e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	2.52e-06	5.73e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.51e-06	5.72e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	2.5e-06	5.7e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.5e-06	5.69e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.48e-06	5.66e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	2.48e-06	5.65e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.47e-06	5.64e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.47e-06	5.64e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	2.47e-06	5.62e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	2.46e-06	5.6e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.45e-06	5.59e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.45e-06	5.59e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.43e-06	5.53e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.42e-06	5.51e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.42e-06	5.51e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.42e-06	5.51e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.41e-06	5.5e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.39e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	2.39e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	2.39e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.37e-06	5.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.37e-06	5.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	2.37e-06	5.41e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	5.39e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.35e-06	5.36e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.35e-06	5.35e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.34e-06	5.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.34e-06	5.32e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.33e-06	5.32e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.32e-06	5.29e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.32e-06	5.28e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.32e-06	5.28e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.32e-06	5.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.31e-06	5.26e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	2.31e-06	5.26e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.3e-06	5.24e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.3e-06	5.23e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.29e-06	5.22e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.28e-06	5.19e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.26e-06	5.16e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.26e-06	5.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.26e-06	5.16e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.25e-06	5.13e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.22e-06	5.07e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.21e-06	5.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.21e-06	5.04e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.21e-06	5.03e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	2.21e-06	5.03e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.19e-06	4.99e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.19e-06	4.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.18e-06	4.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.17e-06	4.94e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.16e-06	4.92e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.15e-06	4.9e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.14e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.14e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.13e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.13e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.13e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.12e-06	4.84e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.12e-06	4.83e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.11e-06	4.82e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.11e-06	4.82e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.11e-06	4.81e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.11e-06	4.8e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.1e-06	4.78e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.1e-06	4.78e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.1e-06	4.78e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.1e-06	4.77e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.09e-06	4.77e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.08e-06	4.74e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.08e-06	4.74e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.08e-06	4.74e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.08e-06	4.73e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.07e-06	4.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.07e-06	4.71e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.06e-06	4.7e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.06e-06	4.69e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.04e-06	4.65e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.03e-06	4.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.03e-06	4.63e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.02e-06	4.6e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.02e-06	4.6e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.02e-06	4.59e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.01e-06	4.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.01e-06	4.57e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.01e-06	4.57e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2e-06	4.56e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.99e-06	4.54e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.98e-06	4.51e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.98e-06	4.51e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.96e-06	4.47e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.96e-06	4.46e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.96e-06	4.46e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.94e-06	4.42e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.93e-06	4.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.93e-06	4.39e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.9e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.9e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.89e-06	4.32e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.88e-06	4.29e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.88e-06	4.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.87e-06	4.25e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.87e-06	4.25e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.87e-06	4.25e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.87e-06	4.25e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-06	4.23e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.85e-06	4.2e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.83e-06	4.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.83e-06	4.17e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.83e-06	4.17e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.82e-06	4.15e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.82e-06	4.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.82e-06	4.14e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.81e-06	4.12e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.81e-06	4.12e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.81e-06	4.12e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.81e-06	4.12e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.8e-06	4.1e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.79e-06	4.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.78e-06	4.05e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.78e-06	4.05e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.77e-06	4.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.77e-06	4.03e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.76e-06	4.02e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.75e-06	4e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.75e-06	4e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.75e-06	3.99e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.75e-06	3.98e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.73e-06	3.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.73e-06	3.95e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.73e-06	3.94e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.72e-06	3.93e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.72e-06	3.91e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	3.91e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	3.91e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-06	3.89e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.71e-06	3.89e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.7e-06	3.87e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.69e-06	3.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.69e-06	3.85e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.68e-06	3.82e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.66e-06	3.79e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.65e-06	3.75e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.65e-06	3.75e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.63e-06	3.72e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.63e-06	3.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.62e-06	3.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.62e-06	3.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.62e-06	3.69e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.61e-06	3.68e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.61e-06	3.67e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.61e-06	3.67e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.61e-06	3.66e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	3.66e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.6e-06	3.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.57e-06	3.57e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.56e-06	3.56e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.54e-06	3.52e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.54e-06	3.51e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.51e-06	3.44e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.5e-06	3.43e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.48e-06	3.37e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.48e-06	3.36e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.45e-06	3.31e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.42e-06	3.23e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.41e-06	3.21e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.41e-06	3.2e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.39e-06	3.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.39e-06	3.18e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.39e-06	3.17e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-06	3.17e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.39e-06	3.16e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.39e-06	3.16e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.38e-06	3.15e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.38e-06	3.14e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.38e-06	3.14e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.37e-06	3.12e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.36e-06	3.11e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.35e-06	3.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.33e-06	3.03e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-06	3.02e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-06	3.02e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.29e-06	2.95e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.29e-06	2.95e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.29e-06	2.95e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.27e-06	2.9e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.27e-06	2.89e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	2.88e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.24e-06	2.83e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.24e-06	2.82e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-06	2.78e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-06	2.78e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	2.76e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.21e-06	2.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.21e-06	2.75e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.21e-06	2.75e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.2e-06	2.74e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.19e-06	2.71e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	2.71e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.18e-06	2.7e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.18e-06	2.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-06	2.6e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.12e-06	2.56e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	2.54e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.11e-06	2.52e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	2.51e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	2.48e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.09e-06	2.47e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.08e-06	2.46e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-06	2.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.06e-06	2.42e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-06	2.4e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.03e-06	2.35e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.03e-06	2.35e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	2.31e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	9.45e-07	2.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.27e-07	2.11e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.09e-07	2.07e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.34e-07	1.9e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	8.07e-07	1.84e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.97e-07	1.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.97e-07	1.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	7.88e-07	1.8e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.29e-07	1.66e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.1e-07	1.39e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.95e-07	1.36e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.61e-07	1.28e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.56e-07	1.27e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.75e-07	1.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.67e-07	8.35e-06	CbGpPWpGaD
